AstraZeneca Denies Fast-Tracking Vaccine for White House


Pharmaceutical firm AstraZeneca says it has not had any discussions with any U.S. government officials about an emergency use authorization for its coronavirus vaccine, Politico reports.

The company’s statement comes a day after the Financial Times reported the White House would consider how to grant an emergency use of the AstraZeneca vaccine if a late-stage clinical trial currently taking place in the U.K. and other countries has positive results.